Adverum Biotechnologies Q2 EPS $(0.31) Up From $(0.44) YoY
Portfolio Pulse from Benzinga Newsdesk
Adverum Biotechnologies reported Q2 losses of $(0.31) per share, a 29.55% improvement from $(0.44) per share losses in the same period last year.
August 10, 2023 | 9:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Adverum Biotechnologies reported a 29.55% improvement in its Q2 losses per share year-over-year.
Adverum Biotechnologies reported a significant improvement in its Q2 losses per share compared to the same period last year. This indicates a positive financial performance and could potentially lead to a positive reaction in the stock market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100